News
AAWH
1.280
0.00%
0.000
BTIG sees "murky" road ahead for cannabis reclassification
Healthcare BTIG sees "murky" road ahead for cannabis reclassification. White House to propose that marijuana be reclassified as a less dangerous drug. But BTIG says the process will likely face delays due to legal challenges and lack of clarity on implementation. The cannabis industry has much to gain by having cannabis reclassified from a Schedule I substance to a Schedule III.
Seeking Alpha · 13h ago
Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling
US Drug Enforcement Administration will reschedule cannabis from a Schedule 1 drug to a Schedule 3. The proposed rescheduling of cannabis is the biggest step forward for the cannabis industry in decades. Most cannabis companies will see immediate financial and operational benefits from the move. Cannabis has been in a bull market since last August.
Seeking Alpha · 1d ago
Credit Check: What Does DEA Rescheduling Mean For Cannabis Credit Ratings? Big Companies' Risk-Return Profiles
The DEA's decision to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations of multi-state operators. Viridian Capital Advisors' analysis says several MSOs are navigating different financial paths post-DEA rescheduling. The MSO index surged by 25% immediately after the announcement.
Benzinga · 1d ago
Marijuana opposition group raising money to fight cannabis rescheduling
Anti-marijuana reform group raising money to fight cannabis rescheduling. Smart Approaches to Marijuana opposes the DEA's reported decision to reschedule cannabis as a less dangerous drug. The group says the move would give Big Marijuana billions in tax write-offs. The proposed rescheduled cannabis still needs to go through White House review.
Seeking Alpha · 2d ago
Cannabis banking reform bolstered by new poll
A new poll commissioned by a banking group finds that a majority of Americans support legislation that would allow cannabis businesses to access the U.S. Financial system. 64% of Americans say the legislation would help improve public safety. 54% say opening the banking system to cannabis businesses would help underserved communities.
Seeking Alpha · 2d ago
Schumer eyes more cannabis reforms after ‘historic’ marijuana rescheduling decision
Senate Majority Leader Chuck Schumer says he remains committed to even more cannabis reforms. The U.S. Drug Enforcement Administration announced it plans to reclassify marijuana to a less restrictive category called Schedule III. The decision falls short of marijuana legalization, a cause Schumer has long championed.
Seeking Alpha · 3d ago
Pot stocks rally snuffed day after DEA marijuana rescheduling development
Consumer pot stocks rally snuffed day after DEA marijuana rescheduling development. U.S. Multi-state operators hardest hit are Ayr Wellness and Trulieve Cannabis. Canopy Growth is the worst performer, down 29%. Most Canadian cannabis licensed producers are also struggling.
Seeking Alpha · 3d ago
OMB review of cannabis rescheduling could put measure at risk
White House Office of Management and Budget review of cannabis rescheduling could scuttle the reform. Review could take 70 days to complete. The DEA's likely reclassification of marijuana from a Class I to a Class III controlled substance could be delayed until after the election.
Seeking Alpha · 4d ago
Cannabis stocks settle down after rally on plans to reclassify pot as less dangerous
MarketWatch · 4d ago
AWH Applauds DEA on Decision to Move Cannabis from Schedule I to Schedule III
Ascend Wellness Holdings, Inc. Announces support for the DEA's decision to move cannabis from Schedule I to Schedule III of the Controlled Substances Act. The company is a vertically integrated cannabis operator with assets in six states. Ascend CEO John Hartmann says the DEA decision is a historic step forward for cannabis reform.
PR Newswire · 4d ago
Pot stocks surge on news of cannabis rescheduling
Pot stocks surge on news of cannabis rescheduling. The DEA is set to reclassify marijuana as a less dangerous drug. U.S. Multi-state operators have recorded double-digit percentage gains. Cannabis-related stocks rose sharply higher in afternoon trading Tuesday.
Seeking Alpha · 4d ago
US drug control agency to reschedule marijuana: AP
The DEA is set to reclassify marijuana as a less dangerous drug, the Associated Press reports. The drug is currently categorized under Schedule I alongside dangerous drugs like heroin and LSD. If approved, cannabis will be part of Schedule III, reserved for medications like ketamine and Tylenol.
Seeking Alpha · 4d ago
Marijuana banking measure loses potential avenue to passage
An attempt to attach a measure allowing marijuana businesses to work with the U.S. Banking system to a must-pass aviation bill has been scuttled. The plan was to attach the Secure and Fair Enforcement Regulation Banking Act to the FAA's reauthorization bill. The cannabis council says the measure will not be included in the package.
Seeking Alpha · 5d ago
Weekly Report: what happened at AAWH last week (0422-0426)?
Weekly Report · 6d ago
Cannabis MSOs get date for oral arguments in federal marijuana law case
Federal judge in Massachusetts sets May 22 as the date for oral arguments in federal marijuana law case. Cannabis MSOs argue MSOs should be shielded from federal marijuana prohibition laws in states where the plant is legal. The key issue in the case is whether the federal government can interfere in cannabis businesses in legal states.
Seeking Alpha · 04/26 16:32
Who's Winning In Weed? Analyst Looks At Cannabis Market's Big Players, Where Are The Best Bets?
In the first quarter of 2024, the cannabis sector saw a notable sequential decline in sales across several states. Sales declines were observed in Connecticut and Illinois, with moderate increases in Florida and Pennsylvania. The sector faces a mixed economic landscape in key states like New Jersey and Nevada. Pablo Zuanic & Associates provides insights into the sector's performance.
Benzinga · 04/23 18:08
Marijuana Consumers Are Dealing With Information Overload, Experts At Benzinga Cannabis Conference Discuss Improving Retail Experience
Consumers are looking for variety in the products, says John Hartmann at the Benzinga Cannabis Capital Conference in Florida. Consistency, value points and tech are also key to attracting consumers. The tech is crucial to the experience, as well as the experience of interacting with the customer.
Benzinga · 04/23 16:16
Weekly Report: what happened at AAWH last week (0415-0419)?
Weekly Report · 04/22 11:11
On 4/20 Day, even non-cannabis companies get in the spirit
Seeking Alpha · 04/20 20:59
4/20 Cannabis Retail Frenzy: Leading Brands Ready For Record Sales Surge - Who Will Lead?
Benzinga · 04/20 13:54
More
Webull provides a variety of real-time AAWH stock news. You can receive the latest news about Ascend Wellness through multiple platforms. This information may help you make smarter investment decisions.
About AAWH
Ascend Wellness Holdings, LLC (AWH) is a vertically integrated multi-state operator focused on adult-use cannabis states in limited license markets. The Company is principally focused on cultivating, manufacturing and distributing of cannabis consumer packaged goods, which AWH sells through its retail stores and to third-party licensed cannabis retail stores. It produces consumer-packaged goods in five manufacturing facilities with approximately 74,000 square feet of cumulative canopy and total current capacity of around 38,000 pounds annually. AWH operates in five states, including Illinois, Michigan, Massachusetts, New Jersey, and Ohio. Its product portfolio consists of approximately 102 stock keeping units, across a range of cannabis product categories, including flower, pre-rolls, concentrates, vapes, edibles, and other cannabis-related products. The Company's brands include Ozone, Ozone Reserve, Cookies, 1906 and Airopro. AWH has around 13 operating retail locations.